DECEMBER - JANUARYLIFE SCIENCES REVIEW8IN MY OPINIONithin biopharma, we will look back on this decade as a watershed moment. The confluence of advancement in bioscience and emerging technologies sees us at a tipping point. The biopharmaceutical industry is poised to transform its expanding bank of translatable knowledge of disease, of heterogeneity, of the inner machinery of the human cell, into meaningful treatments. The Sheer Complexity of Biology in Health and DiseaseThe intricacies and mechanisms responsible for human disease can seem as complex and as unstructured as the vastness of the universe. By Araz Raoof, Senior Vice President Global Drug Discovery & External Innovation, Ferring PharmaceuticalsDISCOVERING THE MEDICINES OF THE FUTUREAraz RaoofW
< Page 7 | Page 9 >